The Moderna vaccine is not recommended for people under 30 years old: a dangerous side effect can develop

COVID-19: People Under 30 Should Not Get Moderna Vaccine, Informs The Jerusalem Post.

Photo: Shutterstock

Moderna Inc applied for European approval for the COVID-19 vaccine for children ages 6-11, weeks after it postponed a similar filing with US regulators.

The French public health authority has recommended that people under the age of 30 should receive the Pfizer Comirnaty COVID-19 vaccine, when available, instead of the Moderna Spikevax vaccine, which carries a relatively higher risk of cardiovascular disease.

The Haute Autorite de Sante (HAS), which has no legal authority to prohibit or license drugs, but acts as an advisor to the French health sector, cited "very rare" risks associated with myocarditis, a heart disease that has surfaced in the latest vaccine data Moderna and in the results of a French study published on 8 November.

“Among the population under 30 years of age, this risk appears to be approximately five times lower with Pfizer Comirnaty compared with Moderna Spikevax,” HAS said in a conclusion published on Monday.

The Paris decision came after regulators in several other countries, including Canada, Finland and Sweden, also took a more defensive stance against Spikevax due to heart problems affecting young people.

The European Union's regulatory body EMA last month approved the Moderna booster vaccine for all age groups over 18, at least six months after the second dose.

Earlier this year, the EMA said it had found a possible link between a very rare inflammatory heart disease and the COVID-19 vaccines from Pfizer and Moderna vaccines.

However, according to the EMA, the benefits of these mRNA injections in preventing COVID-19 still outweigh the risks.

On the subject: Between children and work: how to be a good mother and not forget about yourself

French HAS said its recommendation, which will apply regardless of whether the vaccine is used as the first, second or third "booster" dose, will be valid until further scientific evidence is available on the matter.

However, for those over 30, the authorities explicitly recommended the use of the Moderna vaccine, stating that its effectiveness was slightly higher.

Moderna Inc applied for a European approval for the COVID-9 vaccine for children ages 19-6 on November 11, weeks after it postponed a similar filing with US regulators.

In July, the European Union authorized the vaccine for use in adolescents aged 12 to 17, but several countries, including Sweden, have suspended its use in people aged 30 and under due to rare heart-related side effects.

In late October, Moderna reported that the US drug regulatory authority needs more time to complete an analysis for use in the 12 to 17 age group as it studies the risk of heart inflammation, called myocarditis, after vaccination.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York.

The drugmaker has delayed filing a US application for children ages 6 to 11, while the FDA is finalizing its review of vaccine use in the 12 to 17 age group.

The company said earlier in October that its vaccine triggered a strong immune response in children ages 6 to 11, and that it plans to release the data to global regulators soon.

Moderna said Tuesday that it has filed an application with the European Medicines Agency for a 50 microgram dose of the vaccine for children, half of what it would get for adults.

Read also on ForumDaily:

If you want to hire a white man, get permission: an American company has introduced strange rules

'Shot Catcher': how the US is trying to fight mass shootings and does it work

We cannot talk about it, but I cannot remain silent: the USA is turning into a country of racism against whites

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.